Ad5 Fiber Entry and Trafficking in Lacrimal Acini
Ad5 纤维在泪腺泡中的进入和运输
基本信息
- 批准号:7075776
- 负责人:
- 金额:$ 39.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-03 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: A major contribution to ocular morbidity is lacrimal dysfunction, affecting over 10 million Americans. The principal cell of the lacrimal gland and primary contributor of proteins into ocular surface fluid is the lacrimal acinar cell, which is the target of much of the ocular research into the etiology of dry eye diseases including the severe autoimmune disease, Sjogren's syndrome. Ongoing studies are now shedding insights into the precise mechanisms involved in initiation, development and progression of disease, suggesting that identification of prospective therapeutic targets is likely in the not so distant future. However, we are still very limited in our ability to specifically target the next generation of macromolecular drugs, particularly DNA-, protein- or peptide based drugs, to the lacrimal gland, raising the possibility that we may soon identify advanced therapies for treatment of severe dry eye diseases but will be unable to deliver these drugs to the target site. Our focus here is to explore the unusual and possibly unique uptake mechanism utilized for lacrimal acinar internalization of adenovirus serotype 5 (Ad5). We have demonstrated in lacrimal acinar cells that Ad5 utilizes a unique fiber-dependent internalization pathway, in contrast to the penton-dependent internalization described in other systems. We hypothesize that Ad5 may use multiple fiber receptors for binding and entry in lacrimal acini, and further that one or more of these entry pathways is either unusually robust or unique to lacrimal acini, explaining the unusual fiber-dependence of entry in tandem with the high efficiency of viral transduction in lacrimal acini. We propose to characterize the participants in this novel fiber-dependent internalization pathway at the molecular level, with a particular focus on coxsackievirus adenovirus receptor, major histocompatibility complex class 1 and heparin sulfate-glycosaminoglycan receptors, and their different modes of endocytosis. The aims are as follows: Aim #1. Does coxsackievirus adenovirus receptor mediate fiber-dependent Ad5 internalization or free fiber internalization in lacrimal acini? Aim #2. What other receptors participate in fiber-dependent Ad5 internalization or free fiber internalization in lacrimal acini? Aim #3. What intracellular trafficking pathways mediate fiber-dependent Ad5 internalization or free fiber internalization in lacrimal acini? At the conclusion of this work, we will have elucidated the contributions of specific receptors and endocytic internalization pathways responsible for fiber-dependent internalization of Ad5. We will have determined to what extent the recombinant fiber or knob, the terminal region of the fiber protein, can recapitulate these pathways. Finally, we will have tested proof-of-principle experiments to determine whether fiber or knob can facilitate entry of antisense oligonucleotides and proteins into lacrimal acinar cytosol.
描述:对眼部发病率的主要贡献是泪功能障碍,影响了超过1000万美国人。泪腺的主要细胞和蛋白质对眼部表面液的主要因素是泪腺腺泡细胞,这是对干眼症病因的大部分眼科研究的靶标,包括严重的自身免疫性疾病,包括严重的自身免疫性疾病,Sjogren的综合征。现在,正在进行的研究正在洞悉疾病起始,发展和进展所涉及的确切机制,这表明在不久的将来可能会识别前瞻性治疗靶标。但是,我们仍然非常有限地靶向下一代大分子药物,尤其是基于DNA,蛋白质或肽的药物,以靶向泪腺,从而提高了我们很快可能确定严重治疗的晚期治疗的可能性。干眼症,但将无法将这些药物输送到目标部位。我们在这里的重点是探索用于腺病毒血清型5(AD5)的泪腺内在化的异常且可能独特的摄取机制。与其他系统中描述的penton依赖性内部化相反,我们已经在泪腺腺泡细胞中证明了AD5使用了独特的纤维依赖性内部化途径。我们假设AD5可以使用多个纤维受体来结合和进入泪acini,进一步说,这些进入途径中的一个或多个是异常健壮的,或者是富富富富的独特的,这解释了与高的纤维依赖性依赖于高高的纤维依赖性。泪液中病毒转导的效率。我们建议在分子水平的这种新型纤维依赖性内部化途径中表征参与者,特别关注Coxsackievivirus腺病毒受体,主要的组织兼容性复合物1类和硫酸硫酸硫酸盐 - 糖胺聚糖受体,以及它们不同的内细胞增多症模式。目的如下:目标#1。 Coxsackievivirus腺病毒受体是否介导了纤维依赖的AD5内在化或泪acini中的游离纤维内在化?目标#2。其他哪些受体参与纤维依赖性的AD5内在化或泪acini中的游离纤维内在化?目标#3。哪种细胞内运输途径介导纤维依赖的AD5内在化或泪acini中的游离纤维内在化?在这项工作结束时,我们将阐明特定受体和负责AD5纤维依赖性内在化的内吞内部化途径的贡献。我们将确定重组纤维或旋钮(纤维蛋白的末端区域)在多大程度上可以概括这些途径。最后,我们将测试原则实验实验,以确定纤维或旋钮是否可以促进反义寡核苷酸和蛋白质进入富富腺腺泡细胞质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah F Hamm-Alvarez其他文献
Sarah F Hamm-Alvarez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah F Hamm-Alvarez', 18)}}的其他基金
Development of a novel tear-based biomarker assay for diagnosis of Parkinson's disease using RT-QuIC
使用 RT-QuIC 开发一种新型基于泪液的生物标志物检测方法来诊断帕金森病
- 批准号:
10227242 - 财政年份:2020
- 资助金额:
$ 39.14万 - 项目类别:
Development of a novel tear-based biomarker assay for diagnosis of Parkinson's disease using RT-QuIC
使用 RT-QuIC 开发一种新型基于泪液的生物标志物检测方法来诊断帕金森病
- 批准号:
10057848 - 财政年份:2020
- 资助金额:
$ 39.14万 - 项目类别:
Protein-polymer nanomedicine for Sjogren's Syndrome
用于治疗干燥综合症的蛋白质聚合物纳米药物
- 批准号:
10662981 - 财政年份:2017
- 资助金额:
$ 39.14万 - 项目类别:
Ad5 Fiber Entry and Trafficking in Lacrimal Acini
Ad5 纤维在泪腺泡中的进入和运输
- 批准号:
7394357 - 财政年份:2006
- 资助金额:
$ 39.14万 - 项目类别:
Ad5 Fiber Entry and Trafficking in Lacrimal Acini
Ad5 纤维在泪腺泡中的进入和运输
- 批准号:
7447508 - 财政年份:2006
- 资助金额:
$ 39.14万 - 项目类别:
Ad5 Fiber Entry and Trafficking in Lacrimal Acini
Ad5 纤维在泪腺泡中的进入和运输
- 批准号:
7797328 - 财政年份:2006
- 资助金额:
$ 39.14万 - 项目类别:
相似国自然基金
BCL2L1/FUNDC1介导的线粒体自噬失衡调控腺泡细胞铁死亡在急性胰腺炎发病中的作用及机制研究
- 批准号:82370651
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
清胰颗粒调控重症急性胰腺炎腺泡细胞脂质代谢重塑机制诠释“通腑泻浊”新内涵
- 批准号:82374248
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
衣康酸介导KDM3A/H3K9/PARP9轴调控DNA损伤修复在急性胰腺炎腺泡细胞坏死中的作用和机制研究
- 批准号:82370653
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
内质网应激通过sXBP1/HIF-1α/mTOR轴调控腺泡细胞缺陷性自噬在急性胰腺炎发病中的作用及其机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
线粒体丙酮酸载体调控腺泡细胞糖代谢和钙超载减轻急性胰腺炎的功能与机制研究
- 批准号:82270672
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Understanding how exocrine-derived signals promote beta cell growth
了解外分泌信号如何促进 β 细胞生长
- 批准号:
10750765 - 财政年份:2024
- 资助金额:
$ 39.14万 - 项目类别:
Novel mechanisms of regulating endoplasmic reticulum homeostasis in alcoholic pancreatitis
调节酒精性胰腺炎内质网稳态的新机制
- 批准号:
10742433 - 财政年份:2023
- 资助金额:
$ 39.14万 - 项目类别:
Genome organizer SATB1 function in salivary gland and development and growth
基因组组织者 SATB1 在唾液腺及其发育和生长中的功能
- 批准号:
10593721 - 财政年份:2023
- 资助金额:
$ 39.14万 - 项目类别:
Genetic and molecular mechanisms of Xbp-1 mediated salivary gland development and differentiation
Xbp-1介导唾液腺发育和分化的遗传和分子机制
- 批准号:
10678146 - 财政年份:2023
- 资助金额:
$ 39.14万 - 项目类别:
Determining Sox10-mediated plasticity in irradiated salivary gland cells
确定受辐射唾液腺细胞中 Sox10 介导的可塑性
- 批准号:
10606665 - 财政年份:2023
- 资助金额:
$ 39.14万 - 项目类别: